MedPath
HSA Approval

POSATIF POSACONAZOLE GASTRO-RESISTANT TABLETS 100MG

SIN17200P

POSATIF POSACONAZOLE GASTRO-RESISTANT TABLETS 100MG

POSATIF POSACONAZOLE GASTRO-RESISTANT TABLETS 100MG

March 10, 2025

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, DELAYED RELEASE

ORAL

Medical Information

J02AC04

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

AET Laboratories Pvt. Ltd

Active Ingredients

Posaconazole

100 mg

Posaconazole

Documents

Package Inserts

Posatif Posaconazole GR Tablets 100mg PI.pdf

Approved: March 10, 2025

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POSATIF POSACONAZOLE GASTRO-RESISTANT TABLETS 100MG - HSA Approval | MedPath